FDA Plans to Use AI to Speed Up Drug and Food Safety Reviews

The FDA Wants AI To Speed Up Health Care Decisions — Here's Why Experts Are Concerned

A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

The FDA Is Already Outsourcing Drug and Food Analysis to Error-Plagued AI Chatbot

In case you haven't had enough about artificial intelligence, the US Food and Drug Administration is now outsourcing its oversight duties to a large language model (LLM.) In an article published in the Journal of the American Medical Association (JAMA), FDA bureaucrats Marty Makary and Vinay Prasad — the latter of whom is a noted critic of COVID mask mandates and vaccine boosters — laid out a five-point list of priorities that the federal agency…

The Audacity of Hype: Reimagining the FDA, One Shortcut at a Time

When two of medicine’s most outspoken reformers publish a roadmap for the FDA, you expect at least coherence. Instead, we get a curious blend of tech evangelism, selective evidence, and lofty ambitions untethered from the practical messiness of regulation. Let’s just say if this is the revolution, it needs a better peer review — and maybe a clinical trial.

FDA Plans to 'Radically Increase Efficiency' in Drug Approval Process Using AI

The FDA has unveiled a new strategy to expedite the approval process for drugs and medical devices by harnessing the power of AI, while also focusing on improving food safety and rebuilding public trust. The post FDA Plans to ‘Radically Increase Efficiency’ in Drug Approval Process Using AI appeared first on Breitbart.

FDA Plans to Use AI to Speed Up Drug and Food Safety Reviews

Key Takeaways